Our Goal is to Bring Lab-on-Chip Diagnostics to Individuals Anytime and Anywhere

We are TSX Venture (TSX.V: CHIP.H) public company that intends to advance and commercialize novel medical devices for Chronic Kidney Disease through our operating subsidiary My Health Logic Inc.

my health logic logo

Healthcare is Changing

The old hospital centered model is dying, and a new person and home centered model is being born

The new model will require radical change in how we provide lab testing at point-of-care

We believe our proprietary lab-on-chip platform will provide transformative, accessible and affordable point-of-care tests for chronic diseases

Chronic Kidney Disease (CKD) or Chronic Renal Disease (CRD) means your kidneys are damaged and losing their ability to keep you healthy

37Million

1 in 7 American adults are estimated to have CKD. It is the 9th leading cause of death in the U.S.

$120Billion

In Medicare costs, 2017, for all people with all stages of CKD.

90%

Of people who have CKD don’t know they have it.

Technology

Our Technology is a proprietary lab-on-chip technology clinically validated and patented for Chronic Kidney Disease (CKD) assesment

5 Mintest result

99%accuracy

Disposableunder $0.30 per chip

  • Multiple use, patent pending, microfluidic platform technology
  • Successful proof of concept clinical trial completed
  • 510 (k) pre-market FDA submission plans – accelerated regulatory pathway
patent

my health logic logo

We bring diagnostics to individuals anytime and anywhere.

Visit website

Board of Directors

Zachary Stadnyk
Zachary Stadnyk,
Director

Zachary is a corporate finance and advisory professional, specializing in taking companies public. Mr. Stadnyk is currently the Chief Executive Officer and a Director of DC Acquisition Corp

Graydon Bensler
Graydon Bensler,
CFA, Director

Graydon is a financial professional with diverse experience in the capital markets across a variety of industries. He specializes in corporate finance initiatives and has worked with both

Scientific Development Team

Paul Komenda
Paul Komenda
MD, Co-founder of
Technology

A physician scientist with expertise in clinical nephrology, CKD, health economics, and health systems design.
 

Dr. Navdeep Tangri
Dr. Navdeep Tangri,
Ph.D – Co-founder of Technology

A epidemiologist and clinical nephrologist with expertise in CKD risk prediction and the lead author of the Kidney Failure Risk Equation.

Francis Lin
Francis Lin
Ph.D. Co-founder of Technology

Dr. Francis Lin is the lead inventor of Health Logic’s lab-on-chip technology. Dr. Lin joined the University of Manitoba and is currently a tenured Full Professor in Physics, Immunology and Biological Sciences.

Jiandong Wu
Jiandong Wu,
Ph.D – Co-founder of Technology

Dr. Wu’s research focuses on developing microfluidic chips and systems for in vitro cell migration studies and in vitro diagnostics.

Strategic Advisors

Dr Susy Santos
Dr. Susy Santos,
IIP Doctorate

Dr. Susy Santos is a diversely experienced leader in healthcare. She is a highly qualified strategic decision-maker in overseeing operations in both clinical and community health services.

Marta New
Marta New,
Ph.D

Marta is a founder and CEO of a preclinical CRO Radyus Research, focused on early stage product development. Prior to starting Radyus, Marta was the co-founding Partner

Matthew Mingay
Matthew Mingay,
Scientist

Matt Mingay holds an MSc in Microbiology & Immunology from the University of British Columbia (UBC) and a BSc in Medical Sciences and Genetics from the University of Western Ontario. He specializes in data science, bioinformatics and DNA sequencing and has authored several top-tier scientific publications.